These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22669594)
1. Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins. Kumar N; Shishu ; Bansal G; Kumar S; Jana AK AAPS PharmSciTech; 2012 Sep; 13(3):863-74. PubMed ID: 22669594 [TBL] [Abstract][Full Text] [Related]
2. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt. Kumar N; Shishu ; Bansal G; Kumar S; Jana AK Drug Dev Ind Pharm; 2013 Feb; 39(2):342-51. PubMed ID: 22553909 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product. Alsarra IA; Alanazi FK; Ahmed SM; Bosela AA; Alhamed SS; Mowafy HA; Neau SH Arch Pharm Res; 2010 Jul; 33(7):1009-17. PubMed ID: 20661710 [TBL] [Abstract][Full Text] [Related]
4. Hot-melt extrusion as a continuous manufacturing process to form ternary cyclodextrin inclusion complexes. Thiry J; Krier F; Ratwatte S; Thomassin JM; Jerome C; Evrard B Eur J Pharm Sci; 2017 Jan; 96():590-597. PubMed ID: 27687637 [TBL] [Abstract][Full Text] [Related]
5. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411 [TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole. Taupitz T; Dressman JB; Buchanan CM; Klein S Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048 [TBL] [Abstract][Full Text] [Related]
7. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388 [TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. Tao T; Zhao Y; Wu J; Zhou B Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T; Sandhu HK; Talele TT; Serajuddin AT Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566 [TBL] [Abstract][Full Text] [Related]
11. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534 [TBL] [Abstract][Full Text] [Related]
12. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery. Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714 [TBL] [Abstract][Full Text] [Related]
13. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
14. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods. Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678 [TBL] [Abstract][Full Text] [Related]
15. When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media. Cuoco A; Eriksen JB; Luppi B; Brandl M; Bauer-Brandl A J Pharm Sci; 2023 May; 112(5):1372-1378. PubMed ID: 36539063 [TBL] [Abstract][Full Text] [Related]
16. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems. Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117 [TBL] [Abstract][Full Text] [Related]
17. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397 [TBL] [Abstract][Full Text] [Related]
18. Development of stabilized itraconazole nanodispersions by using high-gravity technique. Zhang ZL; Le Y; Wang JX; Zhao H; Chen JF Drug Dev Ind Pharm; 2012 Dec; 38(12):1512-20. PubMed ID: 22435399 [TBL] [Abstract][Full Text] [Related]
19. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances. Srivalli KM; Mishra B AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622 [TBL] [Abstract][Full Text] [Related]
20. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies. Alhowyan AA; Altamimi MA; Kalam MA; Khan AA; Badran M; Binkhathlan Z; Alkholief M; Alshamsan A J Microbiol Methods; 2019 Jun; 161():87-95. PubMed ID: 30738109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]